Amneal pharmaceuticals, inc. (AMRX)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17
Cash flows from operating activities:
Net income (loss)

121,517

-64,903

-363,392

-50,526

-124,752

-20,330

17,465

-250,090

51,652

0

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization

58,083

54,303

53,358

50,706

48,868

47,493

43,013

32,146

14,751

-

Amortization of Levothyroxine Transition Agreement asset

0

0

0

0

36,393

10,423

0

0

0

-

Unrealized foreign currency loss

-5,514

3,210

-14,247

10,185

-6,490

2,978

-4,528

-25,359

8,327

-

Amortization of debt issuance costs and discount

2,004

-

-

-

1,601

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

1,780

1,643

1,407

1,170

-

Gain on sale of international business

0

328

0

-1,888

8,818

-146

-2,812

0

0

-

Intangible asset impairment charges

2,416

14,171

79,514

3,012

76,084

38,600

8,474

0

0

-

Deferred tax benefit

0

33

389,892

-8,325

-9,884

-328

5,882

-14,481

-512

-

Stock-based compensation

4,539

5,013

6,095

6,224

4,347

3,606

3,590

160,401

0

-

Inventory provision

15,200

14,401

17,434

34,760

15,650

23,784

3,329

14,581

2,845

-

Other operating charges and credits, net

-1,266

-1,364

-2,790

-2,046

-1,109

-89

2,882

-4,358

3,431

-

Changes in assets and liabilities:
Trade accounts receivable, net

60,893

86,269

-116,497

-2,058

165,012

-163,795

14,660

65,032

-4,981

-

Inventories

2,778

-5,513

6,248

5,478

14,180

-11,687

-17,947

24,066

47,589

-

Income taxes receivable associated with the CARES Act

110,069

-

-

-

0

-

-

-

-

-

Prepaid expenses, other current assets and other assets

26,383

2,386

-12,642

-5,957

-22,657

1,028

-14,910

6,598

-1,491

-

Related party receivables

-76

-366

-319

1,310

314

-100

189

-5,802

-5,215

-

Accounts payable, accrued expenses and other liabilities

34,839

3,675

-394

-14,233

695

-26,689

-46,488

4,305

15,325

-

Related party payables

3,695

5,203

-2,200

1,569

656

12

-769

-2,814

-10,542

-

Other current assets and current liabilities

-

-

-

-

-

-

-

-

-

0

Net cash provided by (used in) operating activities

49,026

-50,889

139,910

21,094

-108,410

259,651

62,129

-98,579

27,029

0

Cash flows from investing activities:
Purchases of property, plant and equipment

7,367

4,517

13,035

11,641

17,988

20,023

26,465

17,101

19,499

-

Acquisition of intangible assets

1,050

250

0

50,000

0

0

11,000

-2,000

5,000

-

Acquisitions, net of cash acquired

253,625

0

0

0

0

-

-

-

-

-

Cash sold with international business

0

-

-

-

3,478

-

-

-

0

-

Net cash used in investing activities

-262,042

-4,767

29,982

-23,329

-21,466

5,321

-40,775

-341,425

-19,499

0

Cash flows from financing activities:
Proceeds from issuance of debt

180,000

0

0

0

0

-

-

-

-

-

Payments of principal on debt and financing leases

7,158

-

-

-

6,750

-

-

-

-

-

Payments of principal on debt and capital leases

-

-

-

-

-

6,569

6,931

600,008

3,543

-

Net borrowings on revolving credit facility

300,000

-

-

-

0

-

-

-

-

-

Payments of deferred financing costs

4,102

-

-

-

0

-

-

-

-

-

Proceeds from exercise of stock options

5

15

0

375

1,010

635

1,185

1,977

0

-

Employee payroll tax withholding on restricted stock unit vesting

503

0

5

921

0

-

-

-

-

-

Capital contribution from non-controlling interest

-

-

-

-

-

0

0

0

360

-

Acquisition of non-controlling interest

-

-

-

-

-

-

11,775

0

0

-

Acquisition of non-controlling interest

0

-

-

-

2,011

-

-

-

-

-

Tax distribution to non-controlling interest

0

0

0

0

13,494

35,543

0

0

0

-

Distributions to members

-

-

-

-

-

2

0

152,998

30,000

-

Net cash provided by (used in) financing activities

467,979

-7,298

-7,596

-9,075

-21,864

-218,920

82,600

457,241

-33,246

0

Effect of foreign exchange rate on cash

-860

-1,282

-2,260

1,589

-296

534

-351

-1,264

411

-

Net increase (decrease) in cash, cash equivalents, and restricted cash

254,103

-64,236

160,036

-9,721

-152,036

46,586

103,603

15,973

-25,305

0

Supplemental disclosure of cash flow information:
Cash paid for interest

35,386

36,696

40,769

41,071

40,032

42,430

38,684

31,548

18,843

-

Cash (paid) received for income taxes, net

-3,430

-1,602

3,324

-1,180

9,713

40,331

-5,379

1,510

-1,510

-

Supplemental disclosure of non-cash investing and financing activity:
Receivable from the sale of international business

0

-

-

-

35,837

-

-

-

0

-

Payable for acquisition of product rights and licenses

0

-

-

-

50,000

-

-

-

-

-

Related Party
Payments of principal on financing obligation - related party

-

-

-

-

-

-

-

58

63

-

Payments of principal on financing lease - related party

263

563

841

247

619

-

-

-

-

-

Notes payable for acquisitions - related party

36,033

-

-

-

0

-

-

-

-

-